AzTrials
AzTrials

Arthropathy of KneeNCT03958370

Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients

An observational study of Arthropathy of Knee and Arthritis Knee, run by Benaroya Research Institute at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Mobilization and rehabilitation are essential components of a successful functional recovery following total hip and knee arthroplasties. Currently, we have no good measure of how mobile patients are after their surgery. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Fitbit
How many people
70 participants
Where
1 siteUnited States
Study dates
8 Jan 2019to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Any person who is over 18 years old, a procedural candidate (having a total arthroplasty surgery at Virginia Mason Medical Center), and can understand English sufficiently to consent for the study can be included

Who may be able to join

  • primary unilateral total knee arthroplasty
  • ASA class I-IV
  • expected to ambulate with PT on postoperative day 1 or 2
  • no history of chronic opioid or alcohol use
  • no history of delirium
  • ability to read and understand English
  • patient agreement

Who cannot join

  • patient refusal,
  • bilateral arthroplasty patients,
  • patients who are non- ambulatory preoperatively (e.g. wheelchair bound),
  • patients who are not expected to ambulate with PT either due to intraoperative or postoperative complications,
  • patients with contact precautions

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Virginia Mason Medical Center

    Seattle, Washington, 98101

    David B Auyong, MD, 206-223-6980, David.Auyong@virginiamason.org

    David B Auyong, MD

    Recruiting

Other trials in United States

About this study

Mobilization and rehabilitation are essential components of a successful functional recovery following total hip and knee arthroplasties. Currently, we have no good measure of how mobile patients are after their surgery. Recent technological advances in personal activity monitors, such as the Fitbit, might provide medical providers and patients the opportunity to more objectively monitor their postoperative mobility and recovery course. However, these consumer activity monitors have yet to be validated in terms of their accuracy and utility for monitoring mobility in the immediate postoperative setting in arthroplasty patients. Our goal is to validate one of the most popular consumer activity monitors, the Fitbit Zip, in the postoperative total joint arthroplasty patient population.

Read the detailed description

Early mobilization following total hip and knee arthroplasty surgeries is important in decreasing the risk of complications such as deep venous thrombosis, pulmonary embolus, pneumonia, and urinary retention. It is also generally accepted that early mobilization may help prevent late complications such as joint stiffness or arthrofibrosis. Aside from these complications, patient satisfaction and length of hospital stay both seem to be correlated with early mobilization with poor mobility negatively impacting both outcomes. Therefore, it is important for clinicians to ensure that patients are adequately mobilizing in the immediate postoperative period to promote a successful recovery after total hip or knee arthroplasty.

Consumer activity monitors are generally manufactured to be used in a relatively healthy, ambulatory population. Their accuracy has been validated in multiple studies in healthy subjects in a variety controlled settings. Based on these validity studies, it is clear that some of these consumer activity monitors have worse accuracy in certain situations, such as slower-paced walking or in people using assistive devices for ambulation, such as canes. The limitations of these devices in these settings could be problematic for monitoring post-arthroplasty patients since all these patients ambulate slowly, with an altered gait, and with a walker. No studies to date have looked at the accuracy of consumer activity monitors in the immediate postoperative arthroplasty population.

The consumer activity monitor market is rapidly evolving and changing, so much so that monitors used just last year might be obsolete this year. Therefore, rather than examining the accuracy of one device versus another, it is more applicable to determine what location is most accurate for placement of these monitors to help providers counsel patients on proper use postoperatively.

Our goal for this study is to validate and to determine the best location for placement of the Fitbit Zip in the postoperative total joint arthroplasty patient population.

Being tested
Fitbit
Keywords
Fitbit, Activity Monitor, Step Count, Total Knee Replacement, Arthroplasty
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FitbitOther

    Fitbit use during physical therapy session

Study groups in NCT03958370
Study groupRoleWhat they receive
FitbitNot described
Receives: Other: Fitbit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of Step Count Obtained from Fitbit

    Comparing Fitbit step counts to observer counted steps during physical therapy sessions during inpatient stay

    Measured: Postoperative day 0-2

Secondary outcomes (1)
  1. Correlation of Step Count to Distance and Time Ambulated

    See if Fitbit counts are more or less accurate depending on distance and time ambulated

    Measured: Postoperative day 0-2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2019
  2. Study start8 Jan 2019
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion31 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03958370
Sponsor's protocol ID
IRB17-053
Status last verified
May 2019
First submitted
20 May 2019
Last updated
22 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Arthropathy of Knee and Arthritis Knee, run by Benaroya Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David B Auyong, MD (206-223-6980, David.Auyong@virginiamason.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of Step Count Obtained from Fitbit (time frame: Postoperative day 0-2). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in